Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jantscheff

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Medical Oncology (Northwood, London, England)|August 24, 1999
Cancer gene and immunotherapy: recent developmentsP Jantscheff, R Herrmann, C Rochlitz
Archiv Fur Geschwulstforschung|January 1, 1986
Different E-rosetting properties of human peripheral blood NK- and K-cellsP Jantscheff, J Milleck, H Thränhardt
Biomedica Biochimica Acta|January 1, 1986
Differences of K562 leukemia cell clones in the pattern of monoclonal antibody binding and NK cell susceptibilityS Hering, V Böttger, P Jantscheff, et al.
Archiv Fur Geschwulstforschung|January 1, 1986
Search for CEA-like molecules in polymorphonuclear leukocytes of non-human primates using monoclonal antibodiesP Jantscheff, L V Indzhiia, B Micheel
Cancer Immunology, Immunotherapy : CII|August 23, 2002
Cell fusion: an approach to generating constitutively proliferating human tumor antigen-presenting cellsP Jantscheff, G Spagnoli, P Zajac, et al.
Archiv Fur Geschwulstforschung|January 1, 1985
Monoclonal antibodies against the human leukemia cell line K 562V Böttger, S Hering, P Jantscheff, et al.
Journal of Leukocyte Biology|September 25, 1999
Synovial PMN show a coordinated up-regulation of CD66 moleculesM Hönig, H H Peter, P Jantscheff, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 19, 2010
Reduction in human melanoma cell adhesion receptor activity by lysophosphatidylcholine (LPC) treatment - functional characterization and signal pathway analysesM Alexander, M Schlesinger, P Jantscheff, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2010
The impact of lysophosphatidylcholine (LPC) on the signaling pathways in melanoma cells. [corrected]M Alexander, M Schlesinger, P Jantscheff, et al.
Haematology and Blood Transfusion|January 1, 1983
NK and K cells in malignant lymph nodesJ Milleck, P Jantscheff, F Irro, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Medical Oncology (Northwood, London, England)|August 24, 1999
Cancer gene and immunotherapy: recent developmentsP Jantscheff, R Herrmann, C Rochlitz
Archiv Fur Geschwulstforschung|January 1, 1986
Different E-rosetting properties of human peripheral blood NK- and K-cellsP Jantscheff, J Milleck, H Thränhardt
Biomedica Biochimica Acta|January 1, 1986
Differences of K562 leukemia cell clones in the pattern of monoclonal antibody binding and NK cell susceptibilityS Hering, V Böttger, P Jantscheff, et al.
Archiv Fur Geschwulstforschung|January 1, 1986
Search for CEA-like molecules in polymorphonuclear leukocytes of non-human primates using monoclonal antibodiesP Jantscheff, L V Indzhiia, B Micheel
Cancer Immunology, Immunotherapy : CII|August 23, 2002
Cell fusion: an approach to generating constitutively proliferating human tumor antigen-presenting cellsP Jantscheff, G Spagnoli, P Zajac, et al.
Archiv Fur Geschwulstforschung|January 1, 1985
Monoclonal antibodies against the human leukemia cell line K 562V Böttger, S Hering, P Jantscheff, et al.
Journal of Leukocyte Biology|September 25, 1999
Synovial PMN show a coordinated up-regulation of CD66 moleculesM Hönig, H H Peter, P Jantscheff, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 19, 2010
Reduction in human melanoma cell adhesion receptor activity by lysophosphatidylcholine (LPC) treatment - functional characterization and signal pathway analysesM Alexander, M Schlesinger, P Jantscheff, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2010
The impact of lysophosphatidylcholine (LPC) on the signaling pathways in melanoma cells. [corrected]M Alexander, M Schlesinger, P Jantscheff, et al.
Haematology and Blood Transfusion|January 1, 1983
NK and K cells in malignant lymph nodesJ Milleck, P Jantscheff, F Irro, et al.
Pageof 4